Manufacturing Execution System Market Revenue to Cross USD 20.46 Billion by 2035

According to a recently published report by Roots Analysis, the increasing demand for high end data management, real-time data analysis and high production efficiency is anticipated to drive the manufacturing execution systems market

Global Manufacturing Execution Systems Market Overview

The global manufacturing execution system market size is anticipated to grow at a CAGR of 16.02% from 2023 to 2035, reaching USD 20.46 billion by 2035.

The manufacturing execution system is a software solution for managing, monitoring, and optimization of manufacturing processes. These software solutions act as a bridging link between enterprise planning, manufacturing control systems, and delivery of real-time data insight to enhance overall production efficiency. In drug development, quality standards, real-time data analysis, planned timetables, and compliance with regulatory guidelines are closely integrated with manufacturing processes. The growing demand for advanced therapeutics generates pressure on drug developers to adopt innovative technologies that help to improve management efficiency and enhance quality control in the production process. It is interesting to note here that, in January 2024, the FDA also issued a new quality management system regulation that aims to harmonize the cGMP requirements with regulatory standards such as ISO 13485.2016. Driven by the increasing adoption of manufacturing execution systems and ongoing demand for advanced technologies to stream the drug manufacturing process, it is anticipated that the market will expand during the forecast period.

The 119-pages report contains a detailed Table of Contents on the "manufacturing execution system market," Based on Type of Deployment, Type of End User, and Global Forecasts, 2023-2035" here: https://www.rootsanalysis.com/reports/manufacturing-execution-systems-market.html

Market Drivers

Several manufacturing execution systems market drivers that are propelling the growth in this field include increased demand for operational efficiency and high productivity. Further, the increasing complexity within drug manufacturing processes has raised the requirement for advanced technologies like manufacturing execution systems, automation, and data analytics to provide real-time analysis. The rising labor cost and shortage of skilled personnel in the drug manufacturing industry necessities the requirement of manufacturing execution systems.

Market Restraints

Though the requirement for manufacturing execution systems (MES) is gradually increasing in the pharmaceutical and healthcare industry, some restraints hinder market progress. One of the significant restraints is competitiveness among MES suppliers due to the integration of enterprise resource planning systems with manufacturing execution systems. Owing to the complexity associated with dealer landscapes and the requirement of compatibility when utilizing manufacturing execution systems, barriers to the widespread adoption of these systems among drug developers and manufacturers are being created. Further, the high implementation cost associated with the implementation of MES solutions and IT infrastructure is the market restriction that impedes growth.

Growth Factors

The manufacturing execution systems market is likely to grow owing to rising opportunities, such as the growing requirement for cloud-based MES solutions for the enhancement of production capacity. The cloud-based MES solution provides flexibility to manufacturing operations; it serves as a key growth factor driving the manufacturing execution system market. Additionally, the integration of artificial intelligence and machine learning improves data prediction in real-time. Hence, the requirement for predictive data management systems is increasing to find out possible issues with manufacturing machines. The increasing demand for sustainable MES solutions for the optimization of sources and elimination of waste generated during drug manufacturing is driving growth in this field.

Manufacturing Execution Systems Market Segments

Based on the Type of Deployment, The Manufacturing Execution Systems Market is Segmented Into Cloud, Corporate Datacenter, Hybrid and On-Premise.

• Based on the type of deployment, the manufacturing execution system market is dominated by cloud solutions and is poised to capture 68.5% of the overall revenue share by 2035.
• Hybrid solutions are likely to grow at a higher CAGR value of 18.62% during the forecast period.

Based on the Type of End User, The Manufacturing Execution Systems Market is Segmented into Life science / Biotechnology Companies, Medical Device Providers, Pharmaceutical Companies, and Others.

• Based on the type of end-user, the manufacturing execution systems market is dominated by medical device providers, capturing 51% of the overall revenue share by 2035.
• In the long run, life science / biotechnology companies show the highest potential to expand at a higher CAGR of 16.46% during the forecast period.

Based on the Key Geographical Insight, The Manufacturing Execution Systems Market is Segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, Latin America, and the rest of the world.

• Europe will dominate the manufacturing execution systems market and is anticipated to capture 41% of the overall revenue share by 2035.
• In the long run, Asia-Pacific has shown significant potential to grow at a higher compounded annual growth rate (CAGR) of 16.8% during the forecast period.

Key Companies Profiled

The manufacturing execution systems market report also covers the detailed profiles of leading players (listed below) that provide innovative software solutions.

• Andea
• Critical Manufacturing
• Dassault Systèmes
• GE Digital
• Infor
• Körber
• Rockwell Automation

You Can Download Free Sample PDF Copy of This Report At:
https://www.rootsanalysis.com/reports/manufacturing-execution-systems-market/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in market research, competitive intelligence and consulting services. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists, and strategic investors for over a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serving our clients in the best possible way.

Contact us
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com